Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 603-837-5 | CAS number: 134605-64-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Neurotoxicity
Administrative data
Description of key information
Subchronic Oral (diet): NOEL: 1000 ppm, (77.0 mg/kg bw/day / 81.6 mg/kg bw/day), male/female rat, EPA OPP 82-7, Classen 1996
Key value for chemical safety assessment
Effect on neurotoxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 77 mg/kg bw/day
- Study duration:
- subchronic
- Species:
- rat
- Quality of whole database:
- Both available studies were conducted under GLP and in accordance with standardised guidelines. Both studies were assigned a reliability score of 1 according to the criteria of Klimisch (1997) and were considered to be suitable as an accurate reflection of the test material. The quality of the database is high.
Effect on neurotoxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Effect on neurotoxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
The subchronic neurotoxic potential of the test material was determined in a study conducted according to GLP and in line with the standardised guideline EPA OPP 82 -7 (Neurotoxicity Screening Battery). During the study groups of 10 male and 10 female rats were administered test material in the diet, for 90 consecutive days, at concentrations of 0, 100, 300 and 1000 ppm. Mortality, clinical signs, body weight and food consumption were monitored throughout the study. A Functional Observational Battery (FOB) was performed and motor activity was measured pre-test and at test weeks 4, 8 and 13. At necropsy, animals were sacrificed. The brain, spinal cord, peripheral nerves and eyes, as well as the liver (all animals) were collected, prepared for histopathological evaluation and examined microscopically. Neuropathological examination was limited to 5 animals per sex and group. The concentrations of test material in the diet resulted in mean daily test material intakes of 7.8, 23.4 and 77.0 mg/kg in males and 8.7, 26.0 and 81.6 mg/kg in females.
Under the conditions of the study all animals survived and no clinical signs were recorded. Food consumption and body weight development were not affected by treatment. In the absence of altered liver weights, microscopic examination of the liver showed inflammatory cell infiltration, cholangiofibrosis of intrahepatic bile ducts, pigments with Kupffer cells, necrosis of single hepatocytes, cytoplasmic vacuolation, hypertrophy of centrilobular hepatocytes and increased mitotic activity of hepatocytes of males dosed at 1000 ppm with single, minimal findings seen also in one animal each of 300 ppm males and 1000 ppm females. Observation and functional tests conducted during the FOB did not show any effect of toxicological significance and no treatment-related effects on the different motor activity parameters were seen. Macroscopical and microscopical examination of the eyes, optic nerves, and multiple areas of the central and peripheral nervous system of the males and female, control and high dose animals subject to neuropathological examination, did not reveal any treatment-related neuropathic changes. Based on this data, it was concluded that the test material, when administered to rats in the diet at a concentration of 1000 ppm for 90 consecutive days, induced liver toxicity with beginning effects seen in one male at 300 ppm. There were no effects indicative of a potential neurotoxicity. A dietary concentration of 1000 ppm, resulting in a daily intake of 77.0 and 81.6 mg/kg in males and females, respectively, was thus considered to represent the NOEL for neurotoxicity. The NOEL for systemic toxicity was determined to be 100 ppm (equivalent to 7.82 and 8.69 mg/kg for males and females, respectively).
The acute and delayed neurotoxic potential of the test material, when administered to rats as a single oral dose, was determined in a study conducted according to GLP and in line with the standardsed guideline EPA OPP 81-8 (Neurotoxicity Screening Battery). During the study the test material was administered in a single oral dose, by gavage, to ten male and ten female rats. Animals were exposed in a limit test at a nominal concentration of 2000 mg/kg, a vehicle control was run concurrently for comparison. The nominal concentration was analytically confirmed by HPLC to be within 1% of the nominal.
Under the conditions of the test, the test material did not induce any changes in clinical signs, observations and functional tests conducted as part of the Functional Observational Battery and did not affect motor activity neither at the time of peak plasma concentrations nor at later time points throughout the 8 days post-dose. Neuropathological examination did not reveal any morphological changes in the central or peripheral nervous system. The test material was therefore considered not to induce acute or delayed neurotoxicity in rats when given as a single oral dose of 2000 mg/kg.
Justification for selection of effect on neurotoxicity via oral route endpoint:
Classen (1996) was selected as the key study on the basis that this was a reliable 90-day guideline study. The acute Classen (1998) study was entered as supporting information.
Justification for classification or non-classification
In the absense of any neurotoxicological effects in either the repeated dose or acute studies, no classification for this endpoint is required under Directive 67/548/EEC or Regulation (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
Ce site web utilise des cookies afin de vous garantir la meilleure expérience possible sur nos sites web.